BSP Gene Silencing Inhibits Migration, Invasion, and Bone Metastasis of MDA-MB-231BO Human Breast Cancer Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Wang, Jie ^a   Wang, Li ^a   Xia, Bing ^a   Yang, Chuanhong ^a   Lai, Huangwen ^a   Chen, Xiaodong ^a  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; EOSIN; HEMATOXYLIN; MATRIGEL; RETROVIRUS VECTOR; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS INHIBITION; MIGRATION INHIBITION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; TUMOR INVASION; WOUND HEALING; X RAY ANALYSIS;

BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CLONE CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INTEGRIN ALPHAVBETA3; INTEGRIN BETA3; INTEGRIN-BINDING SIALOPROTEIN; NEOPLASM INVASIVENESS; STEM CELLS;

EID: 84877154228     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062936     Document Type: Article

References (34)

1. Talmadge JE, Fidler IJ, (2010) AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70(14): 5649-5669.
2. Yoneda T, (1998) Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 34(2): 240-245.
3. Bellahcène A, Merville MP, Castronovo V, (1994) Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res 54(11): 2823-2826.
4. Bellahcene A, Kroll M, Liebens F, Castronovo V, (1996) Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res 11(5): 665-670.
5. Tu Q, Zhang J, Fix A, Brewer E, Li YP, et al. (2009) Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells. J Cell Physiol 218(1): 135-145.
6. Harris NL, Rattray KR, Tye CE, Underhill TM, Somerman MJ, et al. (2000) Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis. Bone 27(6): 795-802.
7. Goldberg HA, Warner KJ, Li MC, Hunter GK, (2001) Binding of bone sialoprotein, osteopontin and synthetic polypeptides to hydroxyapatite. Connect Tissue Res 42(1): 25-37.
8. Wuttke M, Müller S, Nitsche DP, Paulsson M, Hanisch FG, et al. (2001) Structural characterization of human recombinant and bone-derived bone sialoprotein. Functional implications for cell attachment and hydroxyapatite binding. J Biol Chem 276(39): 36839-36848.
9. Sung V, Stubbs JT 3rd, Fisher L, Aaron AD, Thompson EW, et al (1998) Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins. J Cell Physiol 176(3): 482-94.
10. Diel IJ, Solomayer EF, Seibel MJ, Pfeilschifter J, Maisenbacher H, et al. (1999) Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 5(12): 3914-3919.
11. Zhang JH, Tang J, Wang J, Ma W, Zheng W, et al. (2003) Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model. Int J Oncol 23(4): 1043-8.
12. Adwan H, Bäuerle T, Najajreh Y, et al. (2004) Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells. Int J Oncol 24(5): 1235-1244.
13. Adwan H, Bäuerle TJ, Berger MR, (2004) Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells. Cancer Gene Ther 11(2): 109-120.
14. Cogan G, Bansal AK, Ibrahim S, Zhu B, Goldberg HA, et al. (2004) Analysis of human bone sialoprotein in normal and pathological tissues using a monoclonal antibody (BSP 1.2 mab). Connect Tissue Res 45(1): 60-71.
15. Bäuerle T, Adwan H, Kiessling F, Hilbig H, Armbruster FP, et al. (2005) Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. Int J Cancer 115(2): 177-186.
16. Bäuerle T, Peterschmitt J, Hilbig H, Kiessling F, Armbruster FP, et al. (2006) Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein. Int J Oncol 28(3): 573-583.
17. Peterschmitt J, Bäuerle T, Berger MR, (2007) Effect of zoledronic acid and an antibody against bone sialoprotein II on MDA-MB-231(GFP) breast cancer cells in vitro and on osteolytic lesions induced in vivo by this cell line in nude rats. Clin Exp Metastasis 24(6): 449-459.
18. Elazar V, Adwan H, Bäuerle T, Rohekar K, Golomb G, et al. (2010) Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis. Int J Cancer 126(7): 1749-1760.
19. Liu D, Wang C, Li C, Zhang X, Zhang B, et al. (2011) Production and characterization of a humanized single-chain antibody against human integrin alphav beta3 protein. J Biol Chem. 286(27): 24500-7.
20. Liu H, Radisky DC, Yang D, Xu R, Radisky ES, et al. (2012) MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits. Nat Cell Biol. 14(6): 567-74.
21. Wu YJ, Muldoon LL, Gahramanov S, Kraemer DF, Marshall DJ, et al. (2012) Targeting α(V)-integrins decreased metastasis and increased survival in a nude rat breast cancerbrain metastasis model. J Neurooncol 110(1): 27-36.
22. Boudiffa M, Wade-Gueye NM, Guignandon A, Vanden-Bossche A, Sabido O, et al. (2010) Bone sialoprotein deficiency impairs osteoclastogenesis and mineral resorption in vitro. J Bone Miner Res 25(12): 2669-79.
23. Gordon JA, Sodek J, Hunter GK, Goldberg HA, (2009) Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells. J Cell Biochem 107(6): 1118-28.
24. Wang L, Wang J, Yang D, Yang C, Xia B, et al. (2011) Inhibitory effect of bone sialoprotein silencing on the adhesion ability of breast cancer cells to bone matrix. Sheng Wu Gong Cheng Xue Bao 27(2): 233-239.
25. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R, et al. (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16(8): 1486-95.
26. Adorno M, Cordenonsi M, Montagner M, Dupont S, Wong C, et al. (2009) A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 137(1): 87-98.
27. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, et al. (1996) Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98(7): 1544-9.
28. Sterling JA, Edwards JR, Martin TJ, Mundy GR, (2011) Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone 48(1): 6-15.
29. Jensen AØ, Jacobsen JB, Nørgaard M, Yong M, Fryzek JP, et al. (2011) Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer 11: 29.
30. Bellahcène A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS, et al. (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 8(3): 212-26.
31. Byzova TV, Kim W, Midura RJ, Plow EF, (2000) Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone Sialoprotein. Exp Cell Res 254(2): 299-308.
32. Onishi T, Hayashi N, Theriault RL, Hortobagyi GN, Ueno NT, (2010) Future directions of bone-targeted therapy for metastatic breast cancer. Nat Rev Clin Oncol 7(11): 641-651.
33. Pécheur I, Peyruchaud O, Serre CM, Guglielmi J, Voland C, et al. (2002) Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J 16(10): 1266-8.
34. Gordon JA, Sodek J, Hunter GK, Goldberg HA, (2009) Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells. J Cell Biochem 107(6): 1118-28.